Tryptophan pyrrolase was studied in partially purified extracts of Xanthomonas pruni. The dialyzed enzyme required both heme and ascorbate for maximal activity. Other reducing agents were able to substitute for ascorbate. Protoporphyrin competed with heme for the enzyme, suggesting that the native enzyme is a hemoprotein. The enzyme exhibited sigmoid saturation kinetics. Reduced nicotinamide adenine dinucleotide (NADH), reduced nicotinamide adenine dinucleotide phosphate (NADPH), nicotinic acid mononucleotide, and anthranilic acid enhanced the sigmoid kinetics and presumably bound to allosteric sites on the enzyme. The sigmoid kinetics were diminished in the presence of a-methyltryptophan. NAD, NADP, nicotinic acid, nicotinamide, nicotinamide mononucleotide, and several other related compounds were without effect on the activity of the enzyme. These data indicate that the activity of the enzyme is under feedback regulation by the ultimate end products of the pathway leading to NAD biosynthesis, as well as by certain intermediates of this pathway.
The conversion of tryptophan to nicotinamide adenine dinucleotide (NAD) by Xanthomonas pruni has been established by growth (7, 14) , isotope (20) , and genetic studies (3) . Although this pathway has been long known to exist in higher animals (4) and molds (2) , it has only recently been shown to be present in yeast (1) and several species of Streptomyces (10) . The pathway is not present in Escherichia coli, Bacillus subtilis (21) , and several species of Pseudomonas (11) . X. pruni is thus unique among the true bacteria in its ability to convert tryptophan to NAD. We recently showed that the pathway from tryptophan to NAD in this bacterium probably involves the same enzymatic steps that occur in higher animals and Neurospora (3) .
Since tryptophan is necessary for protein synthesis and since NAD can be formed directly from nicotinic acid as well as from tryptophan, we proposed that the conversion of tryptophan to NAD was controlled at the level of tryptophan pyrrolase by products of nicotinate metabolism in a type of feedback mechanism (18) . This proposal was originally made for higher animals based on studies with a partially purified enzyme 'Part of a thesis submitted by Albert T. Brown in partial fulfilhment of the requirements of the Ph.D. degree. 2Present address: National Dental Institute, Bethesda, Md.
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preparation from rat liver. More recent work by Cho-Chung and Pitot (5) has confirmed and extended our original observations. We would now like to extend these studies on the control of tryptophan pyrrolase activity to X. pruni, which can also convert both tryptophan and nicotinic acid to NAD. A summary of the enzymatic steps in the biosynthesis of tryptophan and the conversion of tryptophan to the pyridine nucleotide coenzymes is shown in Fig. 1 . This paper describes the partial purification and properties of tryptophan pyrrolase from X. pruni. Evidence is presented to indicate that tryptophan pyrrolase is an allosteric enzyme, the activity of which can be regulated by both positive and negative effectors. This provides a mechanism for the feedback regulation of tryptophan degradation in this organism.
MATERIALS AND METHODS
Organism and growth conditions. The organism used in this study was the colorless strain of X. pruni, derived from the American Type Culture Collection strain XPI0017 by growth in liquid culture in defined medium as described previously (3). This strain has been shown to convert tryptophan to NAD by the pathway shown in Fig. 1 18 ,000 psi. The ruptured cell suspension was centrifuged at 37,000 X g for 25 min at 4 C, and the supernatant was stored at -25 C.
Preparation of enzyme. All steps were carried out in a cold room at 4 C or in an ice bath. The following purification steps were employed.
Step I. Removal of nucleic acids with streptomycin. A solution of streptomycin sulfate (10 g per 100 ml) was slowly added to the crude cell-free extract with constant stirring until the final concentration of streptomycin was 1 g per 100 ml. The mixture was stirred for 5 min and then centrifuged at 27,000 X g for 15 min. The precipitate was discarded.
Step Step III. Sephadex G-25 treatment. The preparation from step II was passed over a column of Sephadex G-25 to remove any small molecules. The column was equilibrated, and the sample was eluted with 0.05 M Tris buffer (pH 7.4). Since this also removed tryptophan from the enzyme, the resulting preparation was unstable. This step was carried out, therefore, on small portions of the enzyme preparation just prior to assay. The partially purified enzyme was stable for several weeks at -70 C in the presence of 0.001 M L-tryptophan and 0.003 M 2-mercaptoethanol without significant loss of activity.
These steps resulted in an increase in specific activity of sixfold over the original crude, cell-free extract without any loss in total activity. Unless otherwise indicated, the sixfold purified enzyme preparation obtained from step III was used in all experiments.
Assay of tryptophan pyffolase. Tryptophan pyrrolase was measured as described previously (3) by spectrophotometric measurement of formylkynurenine production at 321 nm. The incubation medium contained: 0.03 M L-tryptophan, 0.20 ml; enzyme, 0.15 ml; 0.05 M sodium ascorbate, 0.15 ml; 6.0 X 10-1 M hematin, 0.10 ml; 0.20 M Tris buffer, pH 7.4, 0.40 ml; and enough water to make the total volume 1.5 ml. Assays were carried out at 25 C. A reference reaction was prepared containing all the components of the reaction except the substrate. The reaction was started by the addition of substrate. Rates were measured continuously in a Gilford 2000 recording spectrophotometer.
A unit of enzyme activity is defined as that amount of enzyme which is capable of forming 1 ,umole of formylkynurenine per min under standard assay conditions.
Chemicals. Nicotinic acid mononucleotide (NaMN) was synthesized from nicotinamide mononucleotide (NMN) as described previously (19) . NMN was purchased from P-L Biochemicals, Inc., Milwaukee, Wis., and a-methyl-DL-tryptophan, from Aldrich Chemical Co., Inc., Milwaukee, Wis (15, 17) . Some controversy exists regarding the role played by ascorbate in activating the enzyme. One group of investigators has maintained that the function of ascorbate is to reduce the prosthetic group to the active form, ferroprotoporphyrin (15, 16) , whereas a second group has provided evidence to show that after activation by ascorbate the prosthetic group is in the trivalent, ferriprotoporphyrin form (13) . The data presented in Tables 1 and 2 indicate that tryptophan pyrrolase from X. pruni also requires both hematin and ascorbate for maximal activity. The enzyme preparation was dialyzed overnight against 100 volumes of 0.04 M Tris buffer, pH 7.4, and then was assayed in the presence of either hematin or ascorbate, or in the presence of both. Table 1 shows that in the absence of added hematin the enzymatic activity was only 37% of that in the complete system. The undialyzed enzyme was not stimulated by the addition of hematin. This indicates that the prosthetic group dissociated from 63% of the enzyme during the overnight dialysis. In the absence of added ascorbate, only 5% of the maximal activity was seen, indicating that most of the holoenzyme present after dialysis was in the inactive oxidized form. Table 2 shows that the stimulation by sodium ascorbate was replaced by sulfhydryl compounds. Dithiothreitol was less effective than the monothiols at the same concentration.
Further evidence that heme is the prosthetic group of tryptophan pyrrolase from X. pruni is provided by the inhibition of enzyme activity in the presence of cyanide. Complete inhibition was .025 a The enzyme preparation was dialyzed as described in Table 1. bAll were added at a final concentration of 1.3 X 10-M.
c Expressed as micromoles of product formed per minute per milligram of protein. obtained with 3 X 10-4 M KCN. In addition, protoporphyrin was able to compete with hematin for the apoenzyme. When increasing amounts of protoporphyrin IX were added to the dialyzed enzyme in the presence of both hematin and ascorbate, enzyme activity was inhibited to a maximum of 67% (Fig. 2) . Since only about 37% of the enzyme is present as holoenzyme after dialysis (Table 1) , this suggests that protoporphyrin may only compete with heme for the apoenzyme and not displace enzyme-bound heme during the conditions of the assay.
Inhibition of tryptophan pyrrolase activity. To determine whether any of the intermediate compounds in the biosynthesis of NAD of nicotinamide adenine dinucleotide phosphate (NADP) could function as a feedback inhibitor of tryptophan pyrrolase, the enzyme was assayed in the presence of a number of these compounds. e These values were obtained with an enzyme preparation which had been purified an additional 30-fold by chromatography over diethylaminoethyl cellulose.
various concentrations of these compounds. The only intermediate compounds which were not tested were formylkynurenine and nicotinic acid dinucleotide. Formylkynurenine is the product of tryptophan pyrrolase activity and might be expected to show product inhibition. Nicotinic acid dinucleotide was not available in quantities sufficient for these inhibition studies. The compounds listed in Table 3 fall into two groups. One group produced about 50% inhibition at concentrations of 5 X 10-4 M or less, whereas the second group was not inhibitory at concentrations up to M. The contrast between the inhibitory action of the oxidized and reduced forms of the pyridine nucleotide coenzymes is very striking and has been reported previously for tryptophan pyrrolase from rat liver (5). The inhibition shown by kynurenine was competitive with tryptophan (see below). The inhibition shown by 3-hydroxyanthranilic acid was complex. Reaction rates obtained in the presence of this compound were nonlinear (Fig. 3) . The progressive and complete inhibition of enzyme activity after a short period of incubation may be due to the formation of another, more potent inhibitor from 3-hydroxyanthranilic acid. The values presented in Table 3 were calculated from the rates of reaction during the first minute. In every other case, reaction rates were linear for at least 5 min in the absence or presence of inhibitors.
A number of other compounds were tested for inhibition because of their structural or metabolic relation to the pyridine nucleotide coenzymes. These data are presented in Table 4 . With the exception of anthranilic acid, all were without inhibitory effect upon tryptophan pyrrolase.
Kinetics of inhibition. It was shown in Table 3 that kynurenine is an inhibitor of tryptophan pyrrolase. The inhibition is competitive with respect to the substrate, tryptophan. This is clearly shown by the double reciprocal plot in Fig. 4 . In addition to illustrating competitive nhibition by kynurenine, the data of Table 3 . that at low substrate concentrations the plots are concave upwards, suggesting allosteric behavior of the enzyme (9) . This suggestion of allosteric behavior was also seen when enzyme velocity was plotted against substrate concentrations (Fig. 5) . Sigmoid rather than hyperbolic kinetics were observed. Figure 5 also illustrates the effects of the presence of anthranilic acid and a-methyl-DL-tryptophan upon the substrate saturation curve of tryptophan pyrrolase. Anthranilic acid, which was shown to be a potent inhibitor (Table 4) , not only decreased the maximal velocity of the reaction but also increased the sigmoid nature ofthe substrate saturation curve. On the other hand a-methyl-DLtryptophan had the opposite effect. This suggests cooperative interaction between multiple binding sites for the substrate, and also that this cooperative activity is enhanced in the presence of anthranilic acid and diminished in the presence of a-methyl-DL-tryptophan. When the data of Fig. 5 were replotted according to the Hill equation (Fig. 6 ) the values obtained for n supported the previous conclusions. In the absence of tryptophan, n = 3.32; in the presence of anthranilic acid, the value of n increased to 3.75; in the presence of a-methyl-DL-tryptophan, it decreased to 1.87.
Inhibition by reduced NAD (NADH), reduced NADP (NADPH), and NaMN was of the same type as that caused by anthranilic acid. These compounds all decreased the maximal velocity of the reaction and increased the sigmoid nature of the substrate saturation curve.
The effect of anthranilic acid, NaMN, and NADH upon the shape of double reciprocal velocity-substrate plots is shown in Fig. 7 in comparison with the plot obtained in the absence of inhibitor. These data show that, in the presence of these inhibitors, the Vmax was increased. They also show how this type of plot departs from linearity as a result of the allosteric behavior of tryptophan pyrrolase. The action of these inhibitors is to cause the departure from linearity to occur at higher substrate concentrations (lower values of 1 /s) than in their absence. This departure from linearity is a consequence ofthe sigmoid nature of the substrate saturation curve (Fig. 5) and is accentuated by these inhibitors. The nonlinear nature of the double reciprocal plot makes calculation of a Km value very difficult. In addition, extrapolation of these points to the ordinate in order to obtain an estimate of the Vmax is also uncertain. The data do suggest, however, that these inhibitors are not competitive with tryptophan. This is in contrast to the behavior of kynurenine (Fig. 4) . The double reciprocal plot in the absence and presence of kynurenine clearly shows a common intercept, indicating a reversal of inhibition by high tryptophan concentration. The noncompetitive nature of NADH inhibition upon tryptophan pyrrolase from rat liver has also been shown by Cho-Chung and Pitot (5) . Non-Michaelis-Menten kinetics were also seen when the concentration of inhibitor was varied. kynurenine. This is further evidence that inhibition by each of these two compounds is of a different type.
DISCUSSION
The data presented here support the concept that the conversion of tryptophan to pyridine nucleotides is regulated at the initial step of tryptophan degradation, i.e., tryptophan pyrrolase, by the ultimate end products of the pathway, NADH and NADPH. It is also of interest to note the inhibition exhibited by NaMN. This is the first compound common to both pathways of pyridine nucleotide biosynthesis (from tryptophan and from nicotinamide). Both NaMN and the reduced pyridine nucleotide coenzymes presumably inhibit tryptophan pyrrolase by combining with an allosteric site on the enzyme. These inhibitors do not appear to be competitive with tryptophan, and they apparently enhance cooperative homotropic interactions. It is not known whether the reduced pyridine nucleotides and NaMN share a common ailosteric site on the enzyme, but this seems unlikely in view of the structures of the compounds involved. If NADH, NADPH, and NaMN shared a common site, the structural features requisite for binding these ligands might be those of a pyridine nucleotide (either oxidized or reduced) containing either a carboxyl or carboxamide group in position 3 of the pyridine ring. The fact that oxidized pyridine nucleotide coenzymes and NMN are not inhibitory may indicate that the enzyme contains one site specific for the reduced pyridine nucleotides and another site specific for NaMN.
It is not clear why it is the reduced forms of the coenzymes which act as inhibitors, but there is a marked difference between the ability of the reduced and oxidized species to inhibit tryptophan pyrrolase. It is significant that tryptophan pyrrolase from rat liver which had been exten-sively purified was also inhibited only by the reduced pyridine nucleotide coenzymes (5) .
The regulation of a branched metabolic pathway by feedback inhibition of the step immediately following the branch point by the final end product is a common phenomenon (6) . The situation described here in X. pruni does not involve a branched pathway, but results from the convergence of two pathways for the formation of a single metabolic product. Here, alternate routes are provided for the synthesis of NAD (and NADP), from tryptophan and from nicotinamide. It is therefore beneficial to the economy of the cell for the first intermediate common to both pathways, NaMN, to restrict the conversion of tryptophan along this pathway and conserve it for protein biosynthesis. This is not a strict case of feedback inhibition by end product, but feedback inhibition by a common intermediate, and it is for this reason that a separate allosteric site specific for NaMN may be required.
The inhibition exhibited by anthranilic acid may also be explained on the basis of its ability to spare tryptophan. X. pruni is unique among bacteria in that it contains pathways both for the synthesis of tryptophan and for the conversion of tryptophan to NAD. Anthranilic acid may be formed by both pathways (Fig. 1) . Data published previously showed that anthranilic acid could support the growth of nicotinic acid-requiring mutants of X. pruni (3). These mutants grew on nicotinic acid and kynurenine or formylkynurenine, respectively, but not on tryptophan. They also grew on anthranilic acid. This suggests that a pathway exists for the conversion of anthranilic acid to NAD which does not involve tryptophan as an intermediate. As can be seen in Fig. 1 , this might involve hydroxylation of anthranilic acid to 3-hydroxyanthranilic acid or reversal of the kynureninase reaction. The former possibility has never been demonstrated in bacteria, and the latter is extremely unlikely on mechanistic grounds (12) . Whatever the nature of the alternative conversion of anthranilic acid to NAD, it does result in a sparing of the tryptophan requirement for NAD biosynthesis. Inhibition of tryptophan pyrrolase by anthranilic acid is therefore presumably beneficial to the economy of the organism.
The behavior of a-methyltryptophan (Fig. 5 ) indicates that still another site must be present on tryptophan pyrrolase which results in the decreased homotropic interactions. A similar effect of a-methyltryptophan upon the activity of tryptophan pyrrolase from P. acidovorans has been reported. Feigelson and Maeno have shown that the enzyme from P. acidovorans exhibits sigmoid kinetics and that the sigmoidicity is decreased in the presence of a-methyltryptophan (8) . These authors concluded that tryptophan pyrrolase from P. acidovorans contains two distinct tryptophan binding sites: a catalytic site and a regulatory site, and that a-methyltryptophan binds only to the regulatory site. Our results with the enzyme from X. pruni are consistent with these studies. They also show that the enzyme from X. pruni is inhibited by a number of tryptophan metabolites, including reduced pyridine nucleotide coenzymes and NaMN. These latter compounds presumably bind to a specific site or sites on the enzyme which may or may not be identical with the regulatory site. Further work on a purified enzyme preparation is required to answer any specific questions concerning the mechanism of the allosteric control of tryptophan pyrrolase activity from X. pruni.
The present studies with relatively crude enzyme fractions serve to identify the phenomena of both positive and negative control of the activity of tryptophan pyrrolase from this bacterium and provide a basis for further investigation. LITERATURE CITED
